Jun 12 2007, 11:15 AM EST
News source: Business Wire
PharmaNet Development Group, Inc. (NASDAQ:PDGI), (the "Company"), a leading provider of global drug development services, today announced that it has completed the move of the Quebec City, Canada operations of Anapharm, Inc. ("Anapharm"), a subsidiary of the Company, to a new building in Quebec City. The new facility is completely operational with all staff and equipment in place. The Company has scheduled a grand opening of the facility for today.
The modern facility has approximately 150,000 square feet of laboratories, clinics and open-plan work stations. Anapharm offers clinical-development services including early phase consulting, Phase l and bioequivalence clinical studies and provides bioanalytical analyses to pharmaceutical and generic drug companies. The facility is scaleable and the Company believes it provides the necessary space to expand the Company's laboratory and the new 200-bed clinic in the future.
In addition to this new facility, Anapharm is expected to open another clinical facility by the end of the month in Toronto, Canada, which will include an additional 150 beds for clinical studies.
"The contemporary, bright workspace provides an excellent environment for employees, easy accessibility for clinical study participants and better clinical process flow which we expect to improve productivity and client responsiveness," commented Johane Boucher-Champagne, president and chief executive officer, Anapharm.
Mark Di Ianni, president, early stage development, PharmaNet Development Group, Inc. added, "The investments in Quebec City and Toronto reflect our confidence in our Canadian operations and provide the room for future expansion as Anapharm continues to grow."
"Anapharm plays a strategic role in the many steps that must be taken so that a new medication can emerge and be used in the context of medical treatment," stated Mr. Philippe Couillard, the Minister of Health and Social Services and Minister responsible for the Capital-Nationale Region.
Mr. Couillard continued, "Anapharm's high level of clinical research and bioanalytical capabilities makes it possible for pharmacological treatments to be designed more efficiently which benefits all of the general population. Through its activities, Anapharm contributes to the vitality of the biopharmaceutical industry in Quebec, which is one of the central lines of the Drug Policy that we launched this past February 1st. The Capital-Nationale Region is proud to count Anapharm as one of the innovative organizations within its territory, an organization that contributes to the economic prosperity and outreach of the region on the global markets."
"Anapharm is a key player in the Quebec pharmaceutical industry and corresponds perfectly to the niche of excellence in which we seek to base our knowledge economy," declared the Minister of Employment and Social Solidarity and Deputy of Louis-Hebert, Mr. Sam Hamad. "In addition to the 550 employees at Anapharm headquarters, and a total of 850 employees across Canada, the new facilities allow the creation of 50 permanent and quality jobs in the Capital-Nationale."
Following the official ribbon cutting in late afternoon on June 12th, Anapharm is hosting an inauguration event for local dignitaries, customers and invited guests.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The Company offers clinical-development services including early and late stage consulting, Phase l and bioequivalence clinical studies, bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and more t
ADVERTISEMENT
INTERVIEW:
(BIO) BANKING IN LUXEMBOURG - Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)
...MORE
NewsArticles Blogs| Most Viewed | Most Emailed | Top Searches |
|---|---|---|
| Unclog the Innovation Bottleneck at our Nation’s Universities | ||
| (Bio) Banking in Luxembourg | ||
ADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All